Saturday, 17 October 2026European Markets

ERAMET And DSM KON Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - eramet (era.pa) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
eramet (era.pa) €89.50 3.94% 51.96%
dsm kon (dsm.as) €114.40 2.29% 4.69%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. eramet (era.pa)

3.94% forward dividend yield and 51.96% return on equity

eramet s.a. operates as a mining and metallurgical company in france, asia, europe, north america, and internationally. the company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. it also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. in addition, it operates moanda mine in gabon; nickel mines in new caledonia and indonesia; and mineral sand mine in senegal and argentina. eramet s.a. was incorporated in 1880 and is headquartered in paris, france.

earnings per share

as for profitability, eramet has a trailing twelve months eps of €31.

pe ratio

eramet has a trailing twelve months price to earnings ratio of 2.89. meaning, the purchaser of the share is investing €2.89 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.96%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jun 3, 2022, the estimated forward annual dividend rate is 3.5 and the estimated forward annual dividend yield is 3.94%.

revenue growth

year-on-year quarterly revenue growth grew by 10.3%, now sitting on 5.1b for the twelve trailing months.

more news about eramet.

2. dsm kon (dsm.as)

2.29% forward dividend yield and 4.69% return on equity

koninklijke dsm n.v., a science-based company, engages in health and nutrition businesses in the netherlands, switzerland, rest of europe, north america, latin america, china, rest of asia, and internationally. it operates through animal nutrition & health (anh); health, nutrition & care (hnc); and food & beverage segments. the animal nutrition & health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. the health, nutrition & care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. it offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. the food & beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory foods; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. the company was founded in 1902 and is headquartered in heerlen, the netherlands.

earnings per share

as for profitability, dsm kon has a trailing twelve months eps of €6.26.

pe ratio

dsm kon has a trailing twelve months price to earnings ratio of 18.27. meaning, the purchaser of the share is investing €18.27 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.69%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, dsm kon's stock is considered to be overbought (>=80).

dividend yield

as claimed by morningstar, inc., the next dividend payment is on aug 4, 2022, the estimated forward annual dividend rate is 2.63 and the estimated forward annual dividend yield is 2.29%.

more news about dsm kon.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com